USA, Micell Receives $15 Million Equity Investment

Raleigh, NC.-based Micell Technologies, a development-stage biomedical company dedicated to developing innovative interventional cardiology systems, announced today that St. Jude Medical, Inc. has made a $15m equity investment in the company.
Commenting on the deal, Arthur J. Benvenuto, chairman and chief executive officer of Micell, said, “We are excited to have a company of St. Jude Medical’s stature make an investment in Micell.
“We look forward to collaborating with them to expand the use of our coating technology into potentially new applications for medical device products”.

Join the discussion